儿童禁用!这些中药注射剂危害远超问题疫苗

2018-08-06 Chris 赛柏蓝

除了问题疫苗,对于儿童,这些也是你务必要关注的! 近日,百白破问题疫苗事件,让很多家长忧心忡忡。其实,还有一个问题同样值得大家重点关注,就是中药注射剂。


除了问题疫苗,对于儿童,这些也是你务必要关注的!

近日,百白破问题疫苗事件,让很多家长忧心忡忡。其实,还有一个问题同样值得大家重点关注,就是中药注射剂。

除了问题疫苗,这些也要关注

事实上,一些中药注射剂给儿童带来的风险,可能远远超过问题疫苗。

在今年儿童节前夕,国家药监局发布公告,一款在临床已应用 70 多年的中药注射剂、儿科的常用药——柴胡注射液,因为不良反应等原因,从此被禁用于儿童。

从这次修订说明书开始,大家又开始关注中药注射剂在儿童人群中使用的安全性问题。

说到中药注射剂的安全问题,要追溯到2006年的“鱼腥草注射液事件”。

当时,由于鱼腥草注射液导致的严重不良反应甚至死亡事件频发,国家药监局发布暂停使用鱼腥草等7个注射剂的通告。自从“鱼腥草注射液事件”后,人们对中药注射剂安全性等方面提出了质疑。

对于中药注射剂,冀连梅药师曾发文表示,注射液中出现热原的主要原因是原料带入。因中药注射剂的原料是各种草药,来源复杂,而中药注射液又不要求纯化到单一成分,因此中药注射液容易产生热原,这是中药注射液先天的缺陷。

十大中药注射剂,儿童禁用

以下是根据国家药监局修订说明书公告整理的,部分儿童禁用的中药注射剂,以供参考。

柴胡注射剂

功能主治:用于治疗感冒、流行性感冒及疟疾等的发热。

说明书修改:【禁忌】项目中须注明“儿童禁用”。

双黄连注射剂

功能主治:用于外感风热引起的发热、咳嗽、咽痛。适用于病毒及细菌感染的上呼吸道感染、肺炎、扁桃体炎、咽炎等。

说明书修改:【禁忌】项中须列出“4周岁及以下儿童、孕妇禁用”,并增加警示语“本品不良反应包括过敏性休克”。

茵栀黄注射液

功能主治:用于肝胆湿热,面目悉黄,胸胁胀痛,恶心呕吐,小便黄赤,急性、迁延性、慢性肝炎。

说明书修改:【禁忌】项应当包括“新生儿、婴幼儿禁用”,“孕妇禁用”。

丹参注射液

功能主治:活血化瘀,通脉养心,多用于冠心病胸闷,心绞痛。

说明书修改:【禁忌】项应当包括“新生儿、婴幼儿、孕妇禁用”。

复方蒲公英注射液

功能主治:清热解毒,疏风止咳。用于风热感冒,肺卫热盛,症见发热头痛,咳嗽痰黄。

说明书修改:【禁忌】项下增加 “新生儿、婴儿、孕妇禁用”。

清开灵注射液

功能主治: 清热解毒,化痰通络,醒神开窍。用于热病神昏,中风偏瘫,神志不清,亦可用于急、慢性肝炎,乙型肝炎,上呼吸道感染,肺炎,高烧,以及脑血栓形成、脑出血见上述证候者。

说明书修改:【禁忌】项增加 “新生儿、婴儿、孕妇禁用”。

参麦注射液

功能主治:用于治疗气阴两虚型之休克、冠心病、病毒性心肌炎、慢性肺心病、粒细胞减少症。

说明书修改:“新生儿、婴幼儿禁用”,“孕妇、哺乳期妇女禁用”,老人、儿童等特殊人群被建议“应慎重使用”。

天麻素注射剂

功能主治:用于神经衰弱、神经衰弱综合征及偏头痛、三叉神经痛等血管神经性头痛,也可用于脑外伤性综合征、眩晕症等。

说明书修改:【禁忌】项目中须注明“儿童慎用”。

血塞通注射剂

功能主治:用于中风偏瘫、瘀血阻络证;动脉粥状硬化性血栓性脑梗塞、脑栓塞、视网膜中央静脉阻塞等。

说明书修改:【禁忌】项应增加“儿童禁用”。

生脉注射液

功能主治:用于气阴两亏,脉虚欲脱的心悸、气短、四肢厥冷、汗出、脉欲绝及心肌梗塞、心源性休克、感染性休克等具有上述证候者

说明书修改:【禁忌】项应当包括“新生儿、婴幼儿禁用”,“孕妇禁用”。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1371318, encodeId=043413e13188d, content=<a href='/topic/show?id=d984649e455' target=_blank style='color:#2F92EE;'>#注射剂#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=64974, encryptionId=d984649e455, topicName=注射剂)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5380325, createdName=zchen, createdTime=Wed Aug 08 01:51:00 CST 2018, time=2018-08-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1571879, encodeId=f70615e187994, content=<a href='/topic/show?id=4e5222491c7' target=_blank style='color:#2F92EE;'>#中药注射剂#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22491, encryptionId=4e5222491c7, topicName=中药注射剂)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ac5915776605, createdName=charl1234572, createdTime=Wed Aug 08 01:51:00 CST 2018, time=2018-08-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=337023, encodeId=ddf033e023e7, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKcmgibQ4oCrK7Z6f4CvMcs4k7QUGCkhopcGxvxaBfVciadECSIwaRVttllIOEKumpEaRrq5PoOUxow/0, createdBy=e3bb2081203, createdName=哈哈869, createdTime=Tue Aug 07 11:29:00 CST 2018, time=2018-08-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=336882, encodeId=10b233688227, content=内容非常实用,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/PiajxSqBRaELCAs1uRBgDoWqJaBltta2Y7fTibyM6wYf94osSMg5CCm9oy7JrdcXPqh1DrCdn5IxO4BE8ZLEiaQXQ/0, createdBy=978a1675334, createdName=xiaogan8479, createdTime=Mon Aug 06 20:26:46 CST 2018, time=2018-08-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=336840, encodeId=eff1336840d5, content=内容非常实用,值得分享,借鉴。, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKcmgibQ4oCrK7Z6f4CvMcs4k7QUGCkhopcGxvxaBfVciadECSIwaRVttllIOEKumpEaRrq5PoOUxow/0, createdBy=e3bb2081203, createdName=哈哈869, createdTime=Mon Aug 06 12:28:03 CST 2018, time=2018-08-06, status=1, ipAttribution=)]
    2018-08-08 zchen
  2. [GetPortalCommentsPageByObjectIdResponse(id=1371318, encodeId=043413e13188d, content=<a href='/topic/show?id=d984649e455' target=_blank style='color:#2F92EE;'>#注射剂#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=64974, encryptionId=d984649e455, topicName=注射剂)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5380325, createdName=zchen, createdTime=Wed Aug 08 01:51:00 CST 2018, time=2018-08-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1571879, encodeId=f70615e187994, content=<a href='/topic/show?id=4e5222491c7' target=_blank style='color:#2F92EE;'>#中药注射剂#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22491, encryptionId=4e5222491c7, topicName=中药注射剂)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ac5915776605, createdName=charl1234572, createdTime=Wed Aug 08 01:51:00 CST 2018, time=2018-08-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=337023, encodeId=ddf033e023e7, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKcmgibQ4oCrK7Z6f4CvMcs4k7QUGCkhopcGxvxaBfVciadECSIwaRVttllIOEKumpEaRrq5PoOUxow/0, createdBy=e3bb2081203, createdName=哈哈869, createdTime=Tue Aug 07 11:29:00 CST 2018, time=2018-08-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=336882, encodeId=10b233688227, content=内容非常实用,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/PiajxSqBRaELCAs1uRBgDoWqJaBltta2Y7fTibyM6wYf94osSMg5CCm9oy7JrdcXPqh1DrCdn5IxO4BE8ZLEiaQXQ/0, createdBy=978a1675334, createdName=xiaogan8479, createdTime=Mon Aug 06 20:26:46 CST 2018, time=2018-08-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=336840, encodeId=eff1336840d5, content=内容非常实用,值得分享,借鉴。, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKcmgibQ4oCrK7Z6f4CvMcs4k7QUGCkhopcGxvxaBfVciadECSIwaRVttllIOEKumpEaRrq5PoOUxow/0, createdBy=e3bb2081203, createdName=哈哈869, createdTime=Mon Aug 06 12:28:03 CST 2018, time=2018-08-06, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1371318, encodeId=043413e13188d, content=<a href='/topic/show?id=d984649e455' target=_blank style='color:#2F92EE;'>#注射剂#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=64974, encryptionId=d984649e455, topicName=注射剂)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5380325, createdName=zchen, createdTime=Wed Aug 08 01:51:00 CST 2018, time=2018-08-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1571879, encodeId=f70615e187994, content=<a href='/topic/show?id=4e5222491c7' target=_blank style='color:#2F92EE;'>#中药注射剂#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22491, encryptionId=4e5222491c7, topicName=中药注射剂)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ac5915776605, createdName=charl1234572, createdTime=Wed Aug 08 01:51:00 CST 2018, time=2018-08-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=337023, encodeId=ddf033e023e7, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKcmgibQ4oCrK7Z6f4CvMcs4k7QUGCkhopcGxvxaBfVciadECSIwaRVttllIOEKumpEaRrq5PoOUxow/0, createdBy=e3bb2081203, createdName=哈哈869, createdTime=Tue Aug 07 11:29:00 CST 2018, time=2018-08-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=336882, encodeId=10b233688227, content=内容非常实用,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/PiajxSqBRaELCAs1uRBgDoWqJaBltta2Y7fTibyM6wYf94osSMg5CCm9oy7JrdcXPqh1DrCdn5IxO4BE8ZLEiaQXQ/0, createdBy=978a1675334, createdName=xiaogan8479, createdTime=Mon Aug 06 20:26:46 CST 2018, time=2018-08-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=336840, encodeId=eff1336840d5, content=内容非常实用,值得分享,借鉴。, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKcmgibQ4oCrK7Z6f4CvMcs4k7QUGCkhopcGxvxaBfVciadECSIwaRVttllIOEKumpEaRrq5PoOUxow/0, createdBy=e3bb2081203, createdName=哈哈869, createdTime=Mon Aug 06 12:28:03 CST 2018, time=2018-08-06, status=1, ipAttribution=)]
    2018-08-07 哈哈869

    学习了

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1371318, encodeId=043413e13188d, content=<a href='/topic/show?id=d984649e455' target=_blank style='color:#2F92EE;'>#注射剂#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=64974, encryptionId=d984649e455, topicName=注射剂)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5380325, createdName=zchen, createdTime=Wed Aug 08 01:51:00 CST 2018, time=2018-08-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1571879, encodeId=f70615e187994, content=<a href='/topic/show?id=4e5222491c7' target=_blank style='color:#2F92EE;'>#中药注射剂#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22491, encryptionId=4e5222491c7, topicName=中药注射剂)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ac5915776605, createdName=charl1234572, createdTime=Wed Aug 08 01:51:00 CST 2018, time=2018-08-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=337023, encodeId=ddf033e023e7, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKcmgibQ4oCrK7Z6f4CvMcs4k7QUGCkhopcGxvxaBfVciadECSIwaRVttllIOEKumpEaRrq5PoOUxow/0, createdBy=e3bb2081203, createdName=哈哈869, createdTime=Tue Aug 07 11:29:00 CST 2018, time=2018-08-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=336882, encodeId=10b233688227, content=内容非常实用,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/PiajxSqBRaELCAs1uRBgDoWqJaBltta2Y7fTibyM6wYf94osSMg5CCm9oy7JrdcXPqh1DrCdn5IxO4BE8ZLEiaQXQ/0, createdBy=978a1675334, createdName=xiaogan8479, createdTime=Mon Aug 06 20:26:46 CST 2018, time=2018-08-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=336840, encodeId=eff1336840d5, content=内容非常实用,值得分享,借鉴。, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKcmgibQ4oCrK7Z6f4CvMcs4k7QUGCkhopcGxvxaBfVciadECSIwaRVttllIOEKumpEaRrq5PoOUxow/0, createdBy=e3bb2081203, createdName=哈哈869, createdTime=Mon Aug 06 12:28:03 CST 2018, time=2018-08-06, status=1, ipAttribution=)]
    2018-08-06 xiaogan8479

    内容非常实用,谢谢分享

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1371318, encodeId=043413e13188d, content=<a href='/topic/show?id=d984649e455' target=_blank style='color:#2F92EE;'>#注射剂#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=64974, encryptionId=d984649e455, topicName=注射剂)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5380325, createdName=zchen, createdTime=Wed Aug 08 01:51:00 CST 2018, time=2018-08-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1571879, encodeId=f70615e187994, content=<a href='/topic/show?id=4e5222491c7' target=_blank style='color:#2F92EE;'>#中药注射剂#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22491, encryptionId=4e5222491c7, topicName=中药注射剂)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ac5915776605, createdName=charl1234572, createdTime=Wed Aug 08 01:51:00 CST 2018, time=2018-08-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=337023, encodeId=ddf033e023e7, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKcmgibQ4oCrK7Z6f4CvMcs4k7QUGCkhopcGxvxaBfVciadECSIwaRVttllIOEKumpEaRrq5PoOUxow/0, createdBy=e3bb2081203, createdName=哈哈869, createdTime=Tue Aug 07 11:29:00 CST 2018, time=2018-08-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=336882, encodeId=10b233688227, content=内容非常实用,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/PiajxSqBRaELCAs1uRBgDoWqJaBltta2Y7fTibyM6wYf94osSMg5CCm9oy7JrdcXPqh1DrCdn5IxO4BE8ZLEiaQXQ/0, createdBy=978a1675334, createdName=xiaogan8479, createdTime=Mon Aug 06 20:26:46 CST 2018, time=2018-08-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=336840, encodeId=eff1336840d5, content=内容非常实用,值得分享,借鉴。, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKcmgibQ4oCrK7Z6f4CvMcs4k7QUGCkhopcGxvxaBfVciadECSIwaRVttllIOEKumpEaRrq5PoOUxow/0, createdBy=e3bb2081203, createdName=哈哈869, createdTime=Mon Aug 06 12:28:03 CST 2018, time=2018-08-06, status=1, ipAttribution=)]
    2018-08-06 哈哈869

    内容非常实用,值得分享,借鉴。

    0

相关资讯

2018 ESPGHAN/ESPEN/ESPR儿童肠外营养指南:碳水化物

2018年6月,欧洲儿科胃肠病学、肝病学和营养协会(ESPGHAN)、欧洲临床营养和代谢学会(ESPEN)以及欧洲儿科研究学会(ESPR)共同发布了儿童肠外营养指南碳水化合物的应用。碳水化合物是营养中能量的主要来源,本文主要针对儿童肠外营养治疗中关于碳水化合物的相关内容提出指导建议。

从德国儿童疫苗现状看疫苗监管

最近的问题疫苗事件牵动了大众的神经,甚至引发了全民焦虑。小小疫苗,事关千家万户。相信无数家长都翻看了孩子的接种记录本,一项项对照是否使用过问题疫苗。受到问题疫苗波及的,毫无疑问是担心是愤怒;没有受到影响的,也是胆战心惊,诚惶诚恐。疫苗本应守护孩子的健康,为千家万户带来安全保障,谁想到竟然成了家中的安全隐患。面对问题疫苗,追问后如何解决问题,值得监管部门深思。那么在德国,儿童是如何接种疫苗的呢

Hepatology:miRNA- seq鉴定了一个血清miRNA,结合APRI可以检测和监测存在囊性纤维化中的儿童肝病

本研究在儿科CFLD中发现了一种独特的循环miRNA,它有可能准确鉴别儿童CF患者的肝脏疾病和纤维化严重程度。

Lancet Psychiat:儿童多动症与哮喘存在“明显”关联

英国南安普敦大学领衔开展的一项新研究发现,儿童多动症与哮喘之间存在“明显”关联,这项结果可能会对两种疾病的临床处置产生重要影响,并有望带来对多动症病理生理学的新见解。多动症,又称注意力缺陷多动障碍,是儿童时期常见的一类行为障碍,主要表现为与年龄和发育水平不相称的注意力不集中、活动过度、情绪冲动等。哮喘是一种常见的气道慢性炎症,常导致喘息、气促、胸闷等症状。南安普敦大学等机构研究人员在英国《柳叶刀·

NEJM:儿童服用利福平与异烟肼的安全性及副作用比较

由此可见,在18岁以下的儿童中,使用4个月利福平的治疗具有相似的安全性和疗效,但比异烟肼治疗9个月的依从性更好。

J AAPOS:弱视儿童的OCT血管造影结果

葡萄牙科英布拉大学中心眼科学系的Sobral I近日在J AAPOS发表一项重要工作,他们使用光学相干断层扫描血管造影术(OCT-A),比较了对侧眼儿童和健康儿童在弱视眼的微观结构和血管分布方面的差异。